CEC 1: Evolving International Methodologies
|
|
|
09:00 – 09:10 |
Welcome Remarks Chair: Richard Brown, Switzerland; Mary Gulumian, South Africa |
|
09:10 – 09:50 |
Introduction to the Course Mary Gulumian, NIOH, South Africa |
|
09:50 – 10:30 |
Overview of IPCS Methodologies and their Interrelationships Bette Meek, Uni. of Ottawa, Canada |
|
10:30 – 10:50 |
Break |
|
10:50 – 11:30 |
Update on Latest WHO/IPCS Activities on Chemical Risk Assessment Methodologies, Including the Human Health Risk Assessment Toolkit Richard Brown, WHO, Switzerland |
|
11:30 – 12:10 |
Computational Toxicology in Hazard Characterization and Risk Assessment Bette Meek, Uni. of Ottawa, Canada |
|
12:10 – 12:50 |
Information Resources & Applications: Databases for Hazard & Predictive Application of “Omics” Data Elaine Faustman, Uni. of Washington, USA |
|
12:50 – 13:10 |
Question and Answer Session |
|
13:10 – 14:10 |
Break |
|
14:10 – 17:00 |
Interactive Exercise |
CEC 2: Vaccine Development in the 21st Century |
|
|
09:00 – 09:10 |
Welcome Remarks Chair: Alan Hoberman, Charles River Laboratories, USA |
|
09:10 – 09:50 |
Introduction and History of Vaccines Deborah Novicki, DL Novicki Toxicology Consulting LLC |
|
09:50 – 10:30 |
Non-Clinical Regulatory & Testing Considerations for Vaccine Development in 2021 David Pepperl, Biologics Consulting |
|
10:30 – 10:50 |
Break |
|
10:50 – 11:30 |
Case Studies on Regulatory Toxicology for Prophylactic Vaccines for the Developing and Developed World Alex Rodriguez, GSK, Belgium |
|
11:30 – 12:10 |
Vaccines and Pregnancy: COVID-19 and Special Groups Alan Hoberman, Charles River Laboratories, USA |
|
12:10 – 12:30 |
Question and Answer Session |